课题基金 / 基金详情

Anhedonia and the neural basis of effort-based decision-making in depression

Anhedonia and the neural basis of effort-based decision-making in depression
抑郁症的快感缺乏和基于努力的决策的神经基础
批准号:
8204690
负责人:
DAVID HAROLD ZALD
金额:
$19.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-12-10 至 2013-11-30

项目摘要

项目成果

DAVID HAROLD ZALD的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):快感缺乏一直被认为是重度抑郁症(MDD)的核心症状。基于努力的决策的临床前动物模型为关于快感缺乏的神经和神经药理学基础的假设提供了强有力的基础。这些模型表明中边缘多巴胺向伏隔核的投射在克服反应成本以获得奖励方面的重要性,以及前扣带在评估反应成本方面的重要性。从表面上看,多巴胺耗尽的动物表现出的行为与缺乏快感的MDD的动机缺陷相似。然而,很难将这些临床前模型与MDD的临床研究结合起来,因为:1)临床文献中未能区分快乐(愉悦)和动机缺陷,2)缺乏对人类动机缺陷的客观实验测量,以及3)缺乏专门针对动机或享乐缺陷患者的研究。为了解决这个问题,我们开发并验证了一种新的行为范式,用于探索人类快感缺乏的动机因素。奖励的努力支出任务(efrt)衡量个体在为给定水平的金钱奖励付出努力的意愿上的差异。efrt精心改编自中边缘多巴胺系统和前扣带动物研究中使用的基于努力的决策范式。在人类中,在efrt上的表现已被证明可以预测健康对照组中特质性快感缺乏和多巴胺功能的个体差异。本研究旨在:1)利用事件相关功能磁共振成像(fMRI)研究健康对照(n =24)中努力决策的神经关联,并验证腹侧纹状体和前扣带在预测努力决策中的具体作用的假设;(2)验证efrt检测重度抑郁症和自述动机缺陷个体行为缺陷的敏感性(n=24);(3)检验重度抑郁症患者和自述动机缺陷患者在进行efrt时腹侧纹状体和前扣带激活异常的假设。如果成功,该研究将显著提高我们识别重度抑郁症中快感缺乏症状的特定行为缺陷及其神经生物学基础的能力,并为未来研究利用efrt和fMRI作为临床和临床结果研究的行为或生物标志物提供基础。
英文摘要
DESCRIPTION (provided by applicant): Anhedonia has long been recognized as a core symptom of major depressive disorder (MDD). Preclinical animal models of effort-based decision-making provide a strong basis for hypotheses regarding the neural and neuropharmacological substrates of anhedonia. Such models indicate the importance of mesolimbic dopamine projections to the nucleus accumbens in overcoming response costs in order to obtain rewards, and the importance of the anterior cingulate in evaluating response costs. On the surface, the behaviors displayed by dopamine depleted animals appear similar to the motivational deficits that characterize anhedonic MDD. However, it has been difficult to integrate these preclinical models with clinical studies of MDD, because of: 1) a failure to distinguish between deficits in hedonics (pleasure) and motivation in the clinical literature, 2) the lack of objective experimental measures of motivational deficits in humans, and 3) the dearth of studies specifically targeting patients with motivational or hedonic deficits. To address this issue, we have developed and validated a novel behavioral paradigm for exploration of motivational elements of anhedonia in humans. The Effort Expenditure for Rewards Task (EEfRT) measures individual differences in the willingness to expend effort for a given level of monetary reward. The EEfRT was carefully adapted from effort-based decision-making paradigms used in animal studies of the mesolimbic dopamine system and anterior cingulate. In humans, peformance on the EEfRT has been shown to predict individual differences in trait anhedonia and dopamine function in healthy controls. The present proposal seeks to:1) use event-related fMRI to elucidate the neural correlates of effort-based decisions in healthy controls (n =24), and test hypotheses regarding the specific roles of the ventral striatum and anterior cingulate in predicting effort-based decisions; (2) validate the sensitivity of the EEfRT for detecting behavioral deficits in individuals with MDD and self-reported motivational deficits (n=24); and (3) test the hypothesis that patients with MDD and self-reported motivational deficits will show abnormal ventral striatal and anterior cingulate activations during performance of the EEfRT. If successful, the proposed research will significantly enhance our ability to identify specific behavioral deficits of anhedonic symptoms in MDD, as well as their neurobiological substrates, and provide the basis for future studies on the utility of the EEfRT and fMRI to serve as a behavioral or biomarker for clinical and clinical outcome research. PUBLIC HEALTH RELEVANCE: MDD is predicted to become the second leading cause of death and disability in the United States by the year 2020, and anhedonia remains among the most difficult symptoms to treat in MDD. This proposal provides a unique translation of preclinical models to attempt to both understand the neural substrates of anhedonia and to develop an objective biomarker that could be used to develop treatments particularly tailored for addressing motivational deficits in MDD.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1037/a0028813
发表时间: 2012-08
期刊: JOURNAL OF ABNORMAL PSYCHOLOGY
影响因子: 4.6
作者: [Treadway, Michael T., Bossaller, Nicholas A., Shelton, Richard C., Zald, David H.]
通讯作者: Zald, David H.
DOI: 10.1523/jneurosci.6459-11.2012
发表时间: 2012-05-02
期刊: The Journal of neuroscience : the official journal of the Society for Neuroscience
影响因子: --
作者: [Treadway MT, Buckholtz JW, Cowan RL, Woodward ND, Li R, Ansari MS, Baldwin RM, Schwartzman AN, Kessler RM, Zald DH]
通讯作者: Zald DH
DOI: 10.1016/j.neubiorev.2010.06.006
发表时间: 2011-01
期刊: NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
影响因子: 8.2
作者: [Treadway, Michael T., Zald, David H.]
通讯作者: Zald, David H.
Dopaminergic Neuromodulation of Decision Making in Young and Middle-Aged Adults
  • 批准号:
    9014471
  • 项目类别:
  • 资助金额:
    $52.68万
  • 财政年份:
    2014
  • 负责人:
    DAVID HAROLD ZALD
  • 依托单位:
Dopaminergic Neuromodulation of Decision Making in Young and Middle-Aged Adults
  • 批准号:
    8632817
  • 项目类别:
  • 资助金额:
    $53.29万
  • 财政年份:
    2014
  • 负责人:
    DAVID HAROLD ZALD
  • 依托单位:
Dopaminergic Modulation of Subjective Valuation across Adulthood
  • 批准号:
    8413360
  • 项目类别:
  • 资助金额:
    $53.36万
  • 财政年份:
    2012
  • 负责人:
    DAVID HAROLD ZALD
  • 依托单位:
Dopaminergic Modulation of Subjective Valuation across Adulthood
  • 批准号:
    8549100
  • 项目类别:
  • 资助金额:
    $53.33万
  • 财政年份:
    2012
  • 负责人:
    DAVID HAROLD ZALD
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
  • 批准号:
    82505677
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.00万元
  • 批准年份:
    2025
  • 负责人:
    吕雨霏
  • 依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
  • 批准号:
    82574874
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2025
  • 负责人:
    刘天华
  • 依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位: